BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Vitae Pharmaceuticals, Inc. 

502 West Office Center Drive

Fort Washington  Pennsylvania  19034  U.S.A.
Phone: 215-461-2000 Fax: 215-461-2006


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Vitae Pharmaceuticals, Inc. (VTAE) Reports Third Quarter 2014 Operating And Financial Results 11/13/2014 10:03:13 AM
Vitae Pharmaceuticals, Inc. (VTAE) To Present At Stifel 2014 Healthcare Conference 11/12/2014 10:28:11 AM
Vitae Pharmaceuticals, Inc. (VTAE) To Announce Third Quarter 2014 Financial Results On November 12, 2014 11/6/2014 10:49:02 AM
Vitae Pharmaceuticals, Inc. (VTAE) Announces Exercise Of Underwriters' Option To Purchase Additional Shares Of Initial Public Offering 10/28/2014 7:05:38 AM
Vitae Pharmaceuticals, Inc. (VTAE) Release: Positive Top-Line Results Achieved From Two Phase 1 Clinical Trials Of BACE Inhibitor BI1181181/VTP-37948 In Alzheimer's Disease 10/24/2014 7:39:38 AM
Vitae Pharmaceuticals, Inc. (VTAE) Announces Closing Of Initial Public Offering 9/29/2014 11:23:58 AM
Vitae Pharmaceuticals, Inc. (VTAE) Prices IPO At $8.00 A Share 9/24/2014 7:55:57 AM
Diabetes/Alzheimer's Biotech Vitae Pharmaceuticals, Inc. Sets Terms For $60 Million IPO 9/9/2014 6:51:25 AM
Vitae Pharmaceuticals, Inc. Adds To Leadership Team With Appointment Of Arthur Fratamico As Chief Business Officer, Richard Morris As Chief Financial Officer 7/8/2014 6:26:34 AM
Vitae Pharmaceuticals, Inc. Earns $14 Million Milestone Payment From Boehringer Ingelheim Corporation In Alzheimer's Collaboration 2/20/2014 7:02:42 AM
1234